RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects

By Wang Zhanwei   Dong Hairong   Fu Yuanyuan   Ding Haixia  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 765-769

Springer Publishing Company

Access to resources Recommend Favorite

RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies

By Gao Lin-Bo  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 827-835

Springer Publishing Company

Access to resources Recommend Favorite

RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies

By Yu Ke-Da  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 365-371

Springer Publishing Company

Access to resources Recommend Favorite

Is RAD51 135G>C polymorphism really associated with breast cancer in general population? Biased design and results lead to inappropriate conclusion

By Yu Ke-Da   Li Bin   Zhou Ying   Shao Zhi-Ming  

Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. : 297-300

Springer Publishing Company

Access to resources Recommend Favorite

MTRR A66G polymorphism and breast cancer risk: a meta-analysis

By Hu Jia  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 779-784

Springer Publishing Company

Access to resources Recommend Favorite